Phenol

CHEMBL14060 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
94.1 g/mol
LogP
1.5
Phase
4

Phenol is a simple aromatic compound with antiseptic, disinfectant, local anesthetic, and cauterizing properties that acts by denaturing proteins and disrupting cell membranes at bactericidal concentrations. At low concentrations it has been used in throat sprays, ear drops, and topical analgesics, while at higher concentrations it serves as a chemical denervation and neurolytic agent in pain management procedures.

分子量

94.1100 g/mol

LogP

1.50

TPSA

20.20 Ų

Lipinski 五规则

符合

治疗领域

作用机制

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

机制

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Oc1ccccc1

InChI

InChI=1S/C6H6O/c7-6-4-2-1-3-5-6/h1-5,7H

Molecular Formula

C6H6O

HBD / HBA

1 / 1

可旋转键数

0

重原子数

7

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

Phenol is a simple aromatic compound with antiseptic, disinfectant, local anesthetic, and cauterizing properties that acts by denaturing proteins and disrupting cell membranes at bactericidal concentrations. At low concentrations it has been used in throat sprays, ear drops, and topical analgesics, while at higher concentrations it serves as a chemical denervation and neurolytic agent in pain management procedures.

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Yes, Phenol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL14060. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 996. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.